| « Previous month | Next month » |
Japanese scientists have derived ‘embryonic’ stem cells from tissue taken from discarded human wisdom teeth, potentially bypassing the ethical dilemma of taking them from embryos.
Hungarian researchers have developed a new bioinformatics tool that can identify and correct abnormal, incorrect and mispredicted protein annotations in public databases.
Oxford Diffraction has launched a new dual wavelength X-ray diffractometer that promises to determine the structure of molecules in even the most challenging of crystal samples.
Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.
UK laboratory services firm LGC has brought the first BioMark system into the UK in order to accurately quantify rare gene sequences for its pharmaceutical customers.
Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.
US researchers have developed a new technique that has enabled them to determine the structure of membrane proteins without having to first crystallise the samples.
Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
US researchers have developed a chemoenzymatic strategy to synthesise the anticoagulant drug heparin and avoid the contaminant that has killed more than 80 people.
German biotech and life science laboratory services firm AgenoLab has installed the first xCelligence real-time cell analysis system to bolster its assay offering to customers.
Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.
Dutch assay experts Qiagen reported a 61 per cent jump in revenues helped by its $1.6bn (€1.07bn) acquisition of Digene towards the end of last year.
Researchers have used Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) arrays to discover genetic variations that increase the risk of schizophrenia.
Advalytix’ AmpliGrid technology is playing a key role in enabling researchers to discover how just a single cell can lay a huge role in complex biological systems.
TTP LabTech has launched the RAPid 4 - a flow-based biosensor that can conduct real-time label-free molecular interaction analysis in buffered solutions and in complex biological mixtures.
Veeco Instruments returned to profitability with the company’s ‘best quarterly performance in two years’ even though its metrology unit struggled due to weakness in the semiconductor market.
Bruker recorded a 31 per cent increase in revenue for the second quarter, marking a strong start after it acquired its affiliated Bruker BioSpin in February for $914m.
Integrated DNA Technologies (IDT) has completed the expansion of its European production facility, enabling the company to supply its European customers faster than ever before.
University of York, UK, spin-out Paraytec, has published new results that extend the use of its ActiPix UV area imaging detector to applications in enzyme assays and protein sizing.
Invitrogen’s plans to buy Applied Biosystems (ABI) are on track with US antitrust regulators approving the deal and both firms achieving strong revenue growth.
| « Previous month | Next month » |